4.5 Article

Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Medicine, General & Internal

Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines

Johanna Chapin-Bardales et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Immunology

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2

Stilla Bauernfeind et al.

Summary: This study found that severe adverse reactions after vaccination with the BNT162b2 vaccine can significantly impact humoral immune response in men, but not in women or T-cell-mediated immune response.

VACCINES (2021)

Article Immunology

Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty(R))

Juergen Held et al.

Summary: Adverse effects (AEs) following vaccination with BNT162b2 mRNA show weak correlation with antibody levels against the SARS-CoV-2 spike protein, but have limited predictive value.

VACCINES (2021)

Letter Medicine, General & Internal

SARS-CoV-2 Antibody Response in Persons with Past Natural Infection

Gabriele Anichini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Medicine, General & Internal

Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents

Elizabeth M. White et al.

Summary: The study found that incident SARS-CoV-2 infections decreased significantly after mRNA vaccination in nursing homes, with most infections being asymptomatic.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Can reactogenicity predict immunogenicity after COVID-19 vaccination?

Young Hoon Hwang et al.

Summary: This study found no significant association between the severity of local and systemic adverse events and humoral immunogenicity after SARS-CoV-2 vaccination.

KOREAN JOURNAL OF INTERNAL MEDICINE (2021)

Article Critical Care Medicine

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

David Hillus et al.

Summary: This study evaluated the reactogenicity and immunogenicity of homologous and heterologous COVID-19 vaccinations, with results showing that heterologous immunization has good immunogenicity and tolerability.

LANCET RESPIRATORY MEDICINE (2021)

Article Geriatrics & Gerontology

Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?

Oladayo A. Oyebanji et al.

Summary: The BNT162b2 SARS-CoV-2 mRNA vaccine has shown to be well-tolerated with significantly milder reactogenicity among nursing home residents, who also developed higher antibody titers post-vaccination. The study suggests that absence of reactogenicity could potentially help prioritize vaccine boosters among this vulnerable population.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)

Article Medicine, General & Internal

Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea

Seongman Bae et al.

Summary: A prospective survey conducted in South Korea on healthcare workers who received the first dose of two COVID-19 vaccines showed a higher rate of adverse reactions in the ChAdOx1 group compared to the BNT162b2 group. Females and younger age groups were more likely to experience vaccine-associated adverse reactions.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

Article Medicine, General & Internal

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months

Seiya Yamayoshi et al.

Summary: This longitudinal study on antibody responses against SARS-CoV-2 in symptomatic patients found that IgG titers peaked around 20 days after onset, gradually decreased but maintained for several months. Most patients had neutralizing antibodies at 90 days post-onset, with severe cases having higher initial titers but faster decrease rate.

ECLINICALMEDICINE (2021)

Letter Immunology

Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission

Jennifer Lighter et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy

Giacomo Grasselli et al.

JAMA INTERNAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

Article Multidisciplinary Sciences

Sex differences in immune responses that underlie COVID-19 disease outcomes

Takehiro Takahashi et al.

NATURE (2020)

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Biological sex affects vaccine efficacy and protection against influenza in mice

Ashley L. Fink et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)